Search
 
 
 

WHO WE ARE

Staff, Contact us, About

 
NEWS
New RESPOND publication
The newly published RESPOND Consortium profile looks into the consortium’s ability to address modern challenges for people living with HIV (PLWH).
Find publication here.
 
New COVID-19 treatment trial
The new Phase 3 clinical trial (ACTIV-3) led by Professor Jens Lundgren will investigate the use of antibody treatment in hospitalized COVID-19 patients.
Find out more here.
 
Projects and Collaborations